IGF1-LR3 1MG | Long-Acting Insulin-Like Growth Factor-1 Analog

THESWISSPEP IGF1-LR3 1mg, a long-acting IGF-1 analog for muscle, cell growth, and recovery research. High-potency, research-grade peptide.

THESWISSPEP IGF1-LR3 1mg is a potent, research-grade analog of Insulin-like Growth Factor-1. It has been modified (Long R3) to resist binding to inhibitory proteins, greatly increasing its bioavailability and potency in vitro. This makes it a premier tool for studying the localized effects of IGF-1 on muscle cell growth (hypertrophy), satellite cell activation, nutrient uptake, and general anabolic processes.

Key Features & Benefits:

· Enhanced Potency & Stability: The LR3 modification results in a more powerful and longer-acting research compound compared to standard IGF-1.
· Direct Anabolic Signaling: Binds directly to the IGF-1 receptor to stimulate muscle protein synthesis and cellular proliferation.
· Localized Research Effects: Often studied for its site-specific effects when applied to muscle or tissue cultures.
· High-Potency 1mg Vial: A small amount is highly active, making this an economical choice for cell culture work.
· Ideal For Research Into: Skeletal muscle biology, hypertrophy mechanisms, stem cell (satellite cell) activation, and local tissue growth.

Specifications:

Product Name: IGF1-LR3 

Quantity: 1mg 

Purity: >99% 

Form: Lyophilized Powder

⚠️ CRITICAL DISCLAIMER FOR ALL PRODUCTS:

These products are sold for LABORATORY RESEARCH USE ONLY by qualified professionals. They are NOT for human or veterinary use, not for consumption, not for injection, and not intended as drugs, cosmetics, or supplements. They must be handled only by trained individuals in appropriate laboratory settings.

THESWISSPEP makes no claims regarding the efficacy or safety of these compounds for any purpose outside of controlled scientific research. Purchaser assumes all responsibility for compliance with local, state, and federal regulations regarding the handling and use of research chemicals.